- Home
- CAPR vs SOR Comparison
CAPR vs SOR Comparison
Compare CAPR & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- SOR
- Stock Information
- Founded
- CAPR 2005
- SOR 1968
- Country
- CAPR United States
- SOR United States
- Employees
- CAPR N/A
- SOR N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- SOR Investment Managers
- Sector
- CAPR Health Care
- SOR Finance
- Exchange
- CAPR Nasdaq
- SOR Nasdaq
- Market Cap
- CAPR 332.5M
- SOR 361.3M
- IPO Year
- CAPR N/A
- SOR N/A
- Fundamental
- Price
- CAPR $19.65
- SOR $45.11
- Analyst Decision
- CAPR Strong Buy
- SOR
- Analyst Count
- CAPR 6
- SOR 0
- Target Price
- CAPR $35.50
- SOR N/A
- AVG Volume (30 Days)
- CAPR 1.9M
- SOR 16.2K
- Earning Date
- CAPR 11-13-2024
- SOR 01-01-0001
- Dividend Yield
- CAPR N/A
- SOR 7.24%
- EPS Growth
- CAPR N/A
- SOR N/A
- EPS
- CAPR N/A
- SOR 6.50
- Revenue
- CAPR $27,152,218.00
- SOR N/A
- Revenue This Year
- CAPR N/A
- SOR N/A
- Revenue Next Year
- CAPR $135.53
- SOR N/A
- P/E Ratio
- CAPR N/A
- SOR $6.41
- Revenue Growth
- CAPR 187.15
- SOR N/A
- 52 Week Low
- CAPR $2.68
- SOR $36.41
- 52 Week High
- CAPR $23.40
- SOR $42.75
- Technical
- Relative Strength Index (RSI)
- CAPR 53.80
- SOR 71.41
- Support Level
- CAPR $17.50
- SOR $43.71
- Resistance Level
- CAPR $20.37
- SOR $45.50
- Average True Range (ATR)
- CAPR 1.57
- SOR 0.60
- MACD
- CAPR -0.73
- SOR 0.16
- Stochastic Oscillator
- CAPR 24.91
- SOR 94.40
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.